Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of melatonin on proliferative markers in women with endometrial cancer
TCTR20260113003Phase 2Not yet recruiting
- Sponsor
- Rajavithi Hospital Research Fund
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in endometrial cancer (EC), sponsored by Rajavithi Hospital Research Fund. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on TCTR20260113003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260113003.